Please enable JavaScript to continue using this application.

Compare $CRVS vs $SANA | Chartloom

Compare

$CRVS vs $SANA

Corvus Pharmaceuticals Inc · Sana Biotechnology Inc

CRVS

Corvus Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Compare $CRVS vs $SANA

Comparing Corvus Pharmaceuticals Inc and Sana Biotechnology Inc

CRVSCorvus Pharmaceuticals Inc

SANASana Biotechnology Inc

CRVSCorvus Pharmaceuticals Inc

Market cap

$885M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

43.7%

52W performance

50.3%

FCF yield

-5.1%

SANASana Biotechnology Inc

Market cap

$776M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-33.4%

52W performance

-38.4%

FCF yield

-17.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRVS

SANA

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Market Cap

CRVS$885M

SANA$776M

Enterprise Value

CRVS$866M

SANA$719M

Price

CRVS$10.52

SANA$2.79

P/E Ratio

CRVSN/A

SANAN/A

P/S Ratio

CRVS0.00x

SANA0.00x

EV/Sales

CRVS0.00x

SANA0.00x

EV/EBITDA

CRVS0.00x

SANA0.00x

P/B Ratio

CRVS4.07x

SANA5.60x

P/FCF Ratio

CRVSN/A

SANAN/A

EV/FCF

CRVS-19.14x

SANA-5.33x

PEG Ratio

CRVSN/A

SANAN/A

Forward P/E (NTM)

CRVSN/A

SANAN/A

Forward P/S (NTM)

CRVSN/A

SANAN/A

Revenue (TTM)

CRVS$0

SANA$0

Revenue Growth (YoY)

CRVSN/A

SANAN/A

Forward Rev Growth

CRVS1220.6%

SANA427.6%

Gross Margin (TTM)

CRVS0.0%

SANA0.0%

Operating Margin (TTM)

CRVS0.0%

SANA0.0%

EBITDA Margin (TTM)

CRVS0.0%

SANA0.0%

Net Margin (TTM)

CRVS0.0%

SANA0.0%

FCF Margin (TTM)

CRVSN/A

SANAN/A

Net Income (TTM)

CRVS$-54M

SANA$-212M

FCF (TTM)

CRVS$-45M

SANA$-135M

EPS (TTM)

CRVS-$0.59

SANA-$0.72

ROE (TTM)

CRVS-3615.0%

SANA-13449.0%

ROA (TTM)

CRVS-3362.0%

SANA-5112.0%

ROIC (TTM)

CRVS-3615.0%

SANA-13449.0%

Cash

CRVS$19M

SANA$57M

Debt

CRVS$0

SANA$0

Net Cash/Debt

CRVS$19M

SANA$57M

Current Ratio (TTM)

CRVS16.16x

SANA1.38x

Quick Ratio (TTM)

CRVS15.92x

SANA1.33x

Debt/Equity (TTM)

CRVS0.00x

SANA0.00x

Debt/Assets (TTM)

CRVS0.0%

SANA0.0%

Interest Coverage (TTM)

CRVSN/A

SANAN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

SANA0.00x

Beta

CRVS1.59

SANA2.31

52W Performance

CRVS50.3%

SANA-38.4%

YTD Performance

CRVS43.7%

SANA-33.4%

% from 52W High

CRVS-61.0%

SANA-57.4%

% from 52W Low

CRVS64.6%

SANA6.9%

Asset Turnover (TTM)

CRVS0.00x

SANA0.00x

FCF Yield (TTM)

CRVS-5.1%

SANA-17.4%

Earnings Yield (TTM)

CRVS-6.1%

SANA-27.3%

Dividend Yield (TTM)

CRVSN/A

SANAN/A

Rule of 40

CRVS0.0

SANA0.0

EV/GP/RG

CRVSN/A

SANAN/A

Ticker research

View CRVS research View SANA research

Metric	CRVS Corvus Pharmaceuticals Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$885M	$776M
Enterprise Value	$866M	$719M
Price	$10.52	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1220.6%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-54M	$-212M
FCF (TTM)	$-45M	$-135M
EPS (TTM)	-$0.59	-$0.72
ROE (TTM)	-3615.0%	-13449.0%
ROA (TTM)	-3362.0%	-5112.0%
ROIC (TTM)	-3615.0%	-13449.0%
Financial Health
Cash	$19M	$57M
Debt	$0	$0
Net Cash/Debt	$19M	$57M
Current Ratio (TTM)	16.16x	1.38x
Quick Ratio (TTM)	15.92x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	2.31
52W Performance	50.3%	-38.4%
YTD Performance	43.7%	-33.4%
% from 52W High	-61.0%	-57.4%
% from 52W Low	64.6%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-17.4%
Earnings Yield (TTM)	-6.1%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View SANA research

Valuation

P/S Ratio

CRVS

0.00x

SANA

0.00x

EV/FCF

CRVS

-19.14x

SANA

-5.33x

Growth & revenue

Forward Revenue Growth

CRVS

1220.6%

SANA

427.6%

Profitability & performance

Gross Margin

CRVS

0.0%

SANA

0.0%

ROE

CRVS

-3615.0%

SANA

-13449.0%

FCF Yield %

CRVS

-5.1%

SANA

-17.4%

52-Week Performance

CRVS

50.3%

SANA

-38.4%

Detailed metrics comparison

CRVS

Corvus Pharmaceuticals Inc

SANA

Sana Biotechnology Inc

Market Cap

CRVS$885M

SANA$776M

Enterprise Value

CRVS$866M

SANA$719M

Price

CRVS$10.52

SANA$2.79

P/E Ratio

CRVSN/A

SANAN/A

P/S Ratio

CRVS0.00x

SANA0.00x

EV/Sales

CRVS0.00x

SANA0.00x

EV/EBITDA

CRVS0.00x

SANA0.00x

P/B Ratio

CRVS4.07x

SANA5.60x

P/FCF Ratio

CRVSN/A

SANAN/A

EV/FCF

CRVS-19.14x

SANA-5.33x

PEG Ratio

CRVSN/A

SANAN/A

Forward P/E (NTM)

CRVSN/A

SANAN/A

Forward P/S (NTM)

CRVSN/A

SANAN/A

Revenue (TTM)

CRVS$0

SANA$0

Revenue Growth (YoY)

CRVSN/A

SANAN/A

Forward Rev Growth

CRVS1220.6%

SANA427.6%

Gross Margin (TTM)

CRVS0.0%

SANA0.0%

Operating Margin (TTM)

CRVS0.0%

SANA0.0%

EBITDA Margin (TTM)

CRVS0.0%

SANA0.0%

Net Margin (TTM)

CRVS0.0%

SANA0.0%

FCF Margin (TTM)

CRVSN/A

SANAN/A

Net Income (TTM)

CRVS$-54M

SANA$-212M

FCF (TTM)

CRVS$-45M

SANA$-135M

EPS (TTM)

CRVS-$0.59

SANA-$0.72

ROE (TTM)

CRVS-3615.0%

SANA-13449.0%

ROA (TTM)

CRVS-3362.0%

SANA-5112.0%

ROIC (TTM)

CRVS-3615.0%

SANA-13449.0%

Cash

CRVS$19M

SANA$57M

Debt

CRVS$0

SANA$0

Net Cash/Debt

CRVS$19M

SANA$57M

Current Ratio (TTM)

CRVS16.16x

SANA1.38x

Quick Ratio (TTM)

CRVS15.92x

SANA1.33x

Debt/Equity (TTM)

CRVS0.00x

SANA0.00x

Debt/Assets (TTM)

CRVS0.0%

SANA0.0%

Interest Coverage (TTM)

CRVSN/A

SANAN/A

Net Debt/EBITDA (TTM)

CRVS0.00x

SANA0.00x

Beta

CRVS1.59

SANA2.31

52W Performance

CRVS50.3%

SANA-38.4%

YTD Performance

CRVS43.7%

SANA-33.4%

% from 52W High

CRVS-61.0%

SANA-57.4%

% from 52W Low

CRVS64.6%

SANA6.9%

Asset Turnover (TTM)

CRVS0.00x

SANA0.00x

FCF Yield (TTM)

CRVS-5.1%

SANA-17.4%

Earnings Yield (TTM)

CRVS-6.1%

SANA-27.3%

Dividend Yield (TTM)

CRVSN/A

SANAN/A

Rule of 40

CRVS0.0

SANA0.0

EV/GP/RG

CRVSN/A

SANAN/A

Ticker research

View CRVS research View SANA research

Metric	CRVS Corvus Pharmaceuticals Inc	SANA Sana Biotechnology Inc
Market & Valuation
Market Cap	$885M	$776M
Enterprise Value	$866M	$719M
Price	$10.52	$2.79
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.07x	5.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-19.14x	-5.33x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1220.6%	427.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-54M	$-212M
FCF (TTM)	$-45M	$-135M
EPS (TTM)	-$0.59	-$0.72
ROE (TTM)	-3615.0%	-13449.0%
ROA (TTM)	-3362.0%	-5112.0%
ROIC (TTM)	-3615.0%	-13449.0%
Financial Health
Cash	$19M	$57M
Debt	$0	$0
Net Cash/Debt	$19M	$57M
Current Ratio (TTM)	16.16x	1.38x
Quick Ratio (TTM)	15.92x	1.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.59	2.31
52W Performance	50.3%	-38.4%
YTD Performance	43.7%	-33.4%
% from 52W High	-61.0%	-57.4%
% from 52W Low	64.6%	6.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-5.1%	-17.4%
Earnings Yield (TTM)	-6.1%	-27.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRVS research	View SANA research